We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$83B
AUM Growth
+$4.08B
(+5.2%)
Cap. Flow
-$2.07B
Cap. Flow
% of AUM
-2.5%
Top 10 Holdings %
Top 10 Hldgs %
13.18%
Holding
730
New
59
Increased
161
Reduced
398
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$550M |
| 2 |
Fidelity National Information Services
FIS
|
+$353M |
| 3 |
Global Payments
GPN
|
+$263M |
| 4 |
CVS Health
CVS
|
+$175M |
| 5 |
Devon Energy
DVN
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$433M |
| 2 |
Lowe's Companies
LOW
|
+$277M |
| 3 |
Oracle
ORCL
|
+$226M |
| 4 |
Progressive
PGR
|
+$220M |
| 5 |
Las Vegas Sands
LVS
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.96% |
| 2 | Healthcare | 15.3% |
| 3 | Industrials | 15.12% |
| 4 | Technology | 14.91% |
| 5 | Consumer Discretionary | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Boston Scientific
BSX
$65.8B
| $103M | 0.12% |
2,435,348
-11,160
| -0.5% | -$469K |
|
|
WLL
202
DELISTED
Whiting Petroleum Corporation
WLL
| $102M | 0.12% |
1,575,307
-94,608
| -6% | -$6.2M |
|
203
United Parcel Service
UPS
$97.6B
| $98.6M | 0.12% |
459,831
-27,208
| -6% | -$5.53M |
|
204
Arrow Electronics
ARW
$10.9B
| $97.8M | 0.12% |
728,732
-44,601
| -6% | -$5.47M |
|
205
Ulta Beauty
ULTA
$20.4B
| $97.1M | 0.12% |
235,609
-356,040
| -60% | -$138M |
|
206
Belden
BDC
$4B
| $96.7M | 0.12% |
1,476,483
-37,210
| -2% | -$2.33M |
|
207
Insight Enterprises
NSIT
$3.55B
| $91M | 0.11% |
850,980
-5,989
| -0.7% | -$596K |
|
|
MAXR
208
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $88.1M | 0.11% |
2,982,455
+32,322
| +1% | +$938K |
|
|
MRO
209
DELISTED
Marathon Oil Corporation
MRO
| $86.7M | 0.1% |
5,276,693
-312,440
| -6% | -$5.02M |
|
210
Stride
LRN
$3.69B
| $81.9M | 0.1% |
2,467,324
+22,249
| +0.9% | +$768K |
|
211
Restaurant Brands International
QSR
$25.1B
| $81.7M | 0.1% |
1,347,994
+1,302,318
| +2,851% | +$76.8M |
|
|
SYNH
212
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $78.3M | 0.09% |
769,154
-147,031
| -16% | -$14.1M |
|
213
Dollar General
DG
$25.9B
| $76.9M | 0.09% |
326,023
-18,573
| -5% | -$4.1M |
|
214
Evercore
EVR
$13.1B
| $76.3M | 0.09% |
560,489
-5,041
| -0.9% | -$735K |
|
|
IPG
215
DELISTED
Interpublic Group of Companies
IPG
| $75.7M | 0.09% |
2,020,731
-119,482
| -6% | -$4.34M |
|
216
Biogen
BIIB
$29.9B
| $75.3M | 0.09% |
313,782
-18,807
| -6% | -$4.84M |
|
217
Assured Guaranty
AGO
$3.78B
| $74.6M | 0.09% |
1,473,973
-7,057
| -0.5% | -$363K |
|
218
EnerSys
ENS
$6.95B
| $73.6M | 0.09% |
931,414
+137,930
| +17% | +$10.8M |
|
219
Best Buy
BBY
$18B
| $73.4M | 0.09% |
722,157
-6,285
| -0.9% | -$715K |
|
220
Jazz Pharmaceuticals
JAZZ
$15.9B
| $72M | 0.09% |
565,374
-4,435
| -0.8% | -$583K |
|
221
Allison Transmission
ALSN
$10.1B
| $71.3M | 0.09% |
1,957,775
-4,039,547
| -67% | -$143M |
|
222
Walker & Dunlop
WD
$1.65B
| $71M | 0.09% |
471,626
-3,286
| -0.7% | -$458K |
|
223
Allstate
ALL
$66.9B
| $68.7M | 0.08% |
583,875
-1,000,005
| -63% | -$118M |
|
224
ABM Industries
ABM
$2.8B
| $65.7M | 0.08% |
1,599,990
-4,314
| -0.3% | -$195K |
|
225
US Bancorp
USB
$99.6B
| $63.1M | 0.08% |
1,123,774
-78,169
| -7% | -$4.62M |
|
Similar funds
Boston Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Boston Partners held 730 positions worth $83B, up 5.2% from $78.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Boston Partners's Q4 2021 filing shows 59 new, 161 increased, 398 reduced and 45 closed positions. Its largest new stake was Keurig Dr Pepper: 15,605,496 shares worth $575M. The largest sale was Pfizer, an estimated $433M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q4 2021 buy was Keurig Dr Pepper: 15,605,496 shares worth $575M.
- Boston Partners added most to Fidelity National Information Services in Q4 2021, an estimated $353M increase.
- Boston Partners's biggest Q4 2021 reduction was Pfizer, cutting an estimated $433M.
- Boston Partners fully exited CyrusOne Inc Common Stock in Q4 2021, selling an estimated $137M.
- Boston Partners's ten largest holdings make up 13% of its $83B portfolio in Q4 2021.
- Boston Partners opened 59 new positions and closed 45 in Q4 2021.
- Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $83B.
Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.